Bristol-Myers Sues AstraZeneca Over Cancer Drug Patents
Bristol-Myers has dragged AstraZeneca into Delaware federal court, alleging that it infringed eight Bristol-Myers cancer treatment patents to create a rival immunotherapy drug known as Imfinzi....To view the full article, register now.
Already a subscriber? Click here to view full article